WuXi Biologics (Cayman) Inc.
2269
Classifica tra le azioni
#991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Prezzo delle azioni
$5.73
Capitalizzazione di mercato
$23.57B
Variazione (1 giorno)
-9.03%
Variazione (1 anno)
24.25%
Paese
CN
Scambia WuXi Biologics (Cayman) Inc. (2269)
Categoria
Healthcare
Rapporto P/B per WuXi Biologics (Cayman) Inc. (2269)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di WuXi Biologics (Cayman) Inc., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per WuXi Biologics (Cayman) Inc. da 2014 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2025 | 2.49 | 54.96% |
| 2024 | 1.61 | -40.03% |
| 2023 | 2.68 | -57.33% |
| 2022 | 6.29 | -38.77% |
| 2021 | 10.28 | -41.50% |
| 2020 | 17.56 | 91.24% |
| 2019 | 9.18 | 26.97% |
| 2018 | 7.23 | -26.16% |
| 2017 | 9.80 | -90.76% |
| 2016 | 106.02 | -42.27% |
| 2015 | 183.65 | 166.79% |
| 2014 | 68.84 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 6.251 | - |
US
|
|
| 13.2547 | - |
US
|
|
| 4.208 | - |
AU
|
|
| 6.1824 | - |
NL
|
|
| - | - |
CH
|
